Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
South Korea · Delayed Price · Currency is KRW 9,490.00
-390.00 (-3.95%)
At close: Feb 6, 2026
Vaxcell-Bio Therapeutics Market Cap
Vaxcell-Bio Therapeutics has a market cap or net worth of 220.71 billion as of February 6, 2026. Its market cap has decreased by -12.34% in one year.
Market Cap
220.71B
Enterprise Value
182.67B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
9,490.00
Market Cap Chart
Since September 22, 2020, Vaxcell-Bio Therapeutics's market cap has increased from 160.24B to 220.71B, an increase of 37.74%. That is a compound annual growth rate of 6.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 220.71B | -5.01% |
| Dec 30, 2025 | 232.34B | -3.12% |
| Dec 30, 2024 | 239.82B | -53.54% |
| Dec 28, 2023 | 516.20B | -0.71% |
| Dec 29, 2022 | 519.87B | -21.31% |
| Dec 30, 2021 | 660.68B | -73.75% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ABION | 306.79B |
| Genome & Company | 262.77B |
| curacle co.,ltd. | 254.42B |
| Prestige Biologics | 223.93B |
| ISU Abxis | 215.43B |
| Kangstem Biotech | 196.57B |
| QuadMedicine | 187.36B |
| Bio Solution | 181.29B |